Abstract
| - Cefamandole nafate, a new cephalosporin antibiotic, was used to treat acute urinary tract infection in 31 patients, of whom 26 had pyelonephritis and 5 had cystitis. Eleven of these patients had underlying diseases or complicating factors present which frequently alter clinical response to therapy. Relapse or reinfection occurred with equal frequency in both complicated and uncomplicated groups.
|